Jason Luke practices Oncology. He received awards:"Denise and Michael Kellen-Melanoma Research Alliance Young Investigator", "Merit Award", "Young Investigator Award", "Fellow", "Melvyn Leichtling Oncology Fellow", "Golden Key National Honor Society", "Honors Program" and "Scholarship in Trumpet Performance". Jason Luke is a published doctor and has 8 publications published. The lastest was: 'A Phase Ib/II Study of Gemcitabine and Docetaxel in Combination With Pazopanib for the Neoadjuvant Treatment of Soft Tissue Sarcomas.' He is registered with Medicare.
![]() |
Dr. David T. Ting, MD
![]() ![]() |
![]() |
Dr. Geoffrey Liu, MD |
![]() |
Dr. Sarah Schellhorn, MD
![]() |
![]() |
Dr. Adam B. Lerner, MD
![]() |
![]() |
Dr. David Takeda, MD
![]() |
![]() |
Dr. Tilak K. Sundaresan, MD
![]() |
![]() |
Dr. Christopher S. Lathan, MD
![]() ![]() |
![]() |
Dr. Rizwan Haq, MD
![]() |
![]() |
Dr. Beverly Moy, MD
![]() ![]() |
![]() |
Dr. Jeffrey A. Engelman, MD
![]() ![]() |
![]() |
Dr. Timothy P. Cooley, MD
![]() ![]() |
![]() |
Dr. Peter C. Everett, MD |